CogState Limited (ASX: CGS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CogState Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CogState Limited (ASX: CGS)
Latest News
Small Cap Shares
2 exciting small-cap ASX shares that are growing quickly
Earnings Results
Cogstate share price jumps 5% on FY25 results
Share Gainers
Why Alliance Aviation, Cogstate, Collins Foods, and Findi shares are roaring higher today
Healthcare Shares
Which ASX All Ords stock is up 15% on guidance upgrade?
Share Market News
Returning capital: These ASX companies have been buying back their shares in 2023
Share Gainers
Why CogState, Jumbo, Magellan, and St Barbara shares are rising today
Earnings Results
2 ASX All Ords stocks rocketing over 7% on strong results
Share Fallers
Why Clinuvel, Cogstate, Omni Bridgeway, and Westgold shares are sinking
Earnings Results
3 ASX All Ord shares being hammered on earnings today
Share Fallers
Why A2 Milk, Altium, Cogstate, and Ingenia shares are sinking today
Share Fallers
Why CogState, Downer, Temple & Webster, and Woodside shares are dropping
Opinions
These 2 small-cap ASX shares have soared, but a fund manager still tips them as buys
Frequently Asked Questions
-
No, Cogstate does not pay dividends at this stage.
-
Cogstate Ltd listed on the ASX on 13 February 2004.
CGS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CogState Limited
Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.
The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment.
Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.
